The cost of depression and the costeffectiveness of pharmacological treatment. The British Journal of Psychiatry, 1994: 164,665-673.Jonsson B, Bebbington PE. What price depression? The cost of depression and the cost-effecbveness of pharmacological treatment. Br J Psychiat...
In this paper, we suggest that adherence to antidepressant medication results in substantial improvement in the time to relapse or recurrence of depression. Choice of an SSRI may thus improve treatment outcome by lengthening remission. In addition, this choice is not associated with higher costs. ...
Now the findings of a new survey suggest that many of the sickest patients do not tell their healthcare providers what they are doing. Cost-related medication underuse: Do patients with chronic illnesses tell their doctors? was published in the Sept. 13 issue of the Archives of Internal Medic...
Global spending on prescription drugs in 2020 is expected to be ~$1.3 trillion; the United States alone will spend ~$350 billion1. These high spending rates are expected to increase at a rate of 3–6% annually worldwide. The magnitude of increase is even more alarming for cancer treatments ...
Regardless of age or employment status, roughly half of respondents reporting medication cost hardship said that these problems had become more frequent in 2008 than before the economic recession. These data show that many chronically ill patients, particularly those looking for work or disabled, ...
patients diagnosed with depression and treated with either sertraline, paroxetine, or fluoxetine.Claims records from a national database of patients diagnosed with depression who began treatment with an SSRI in 1995, following an antidepressant medication-free period of at least 6 months, were included...
ContextDepression is a leading cause of functional impairment in elderly individuals and is associated with high medical costs, but there are large gaps
Given these developments, our findings support the use of structured pharmacological interventions in the management of uncomplicated depression in primary care. There is an economic rationale for initially prescribing an antidepressant medication when patients lack strong treatment preferences and there is ...
Comprehensive review of the existing scientific evidence suggests that psychotherapy, particularly cognitive behavior therapy (CBT), is at least as effective as medication in the treatment of depression, even if severe (Antonuccio, Danton, & DeNelsky, 1995). These conclusions hold for ...
When depression has been identified in primary care practice, standard care (SC) can involve a combination of ‘watchful waiting’, advice, psychotherapy, medication, or referral to a specialist [9, 10]. Of the psychological treatments available, cognitive behavioural therapy (CBT) is the most ...